A Phase 1 Dose-Escalation Study of LY3295668 Erbumine As Monotherapy and in Combination with Topotecan and Cyclophosphamide in Children with Relapsed/refractory Neuroblastoma.
Cancer(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined